Tech Company Financing Transactions
QurieGen Funding Round
BSV Ventures, private investors and Lighthouse Ventures participated in a $2.5 million funding round for QurieGen. The financing round was announced on 4/8/2025.
Transaction Overview
Company Name
Announced On
4/8/2025
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its R&D efforts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Toernooiveld 100
Nijmegen, 6526 EC
The Netherlands
Nijmegen, 6526 EC
The Netherlands
Phone
Undisclosed
Website
Email Address
Overview
Our Mission: Advancing drug development with cutting-edge single-cell technologies and predictive disease biology to accelerate the creation of life-changing treatments. Our Vision: Unlocking the full potential of digital biology to ensure every patient has access to breakthrough treatments and precision medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kinga Matula
Browse more venture capital transactions:
Prev: 4/8/2025: Spektion venture capital transaction
Next: 4/8/2025: Adaptis venture capital transaction
Share this article
Where The Data Comes From
We record funding rounds that are announced publicly. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs